Uzbekistan and Saudi Arabia have reached an agreement to expand practical interaction in the field of pharmaceuticals. This cooperation will cover investments, joint projects, technology transfer, and the production of modern medicinal products.
Delegation Visit and Memorandum Signing
The memorandum was signed during the visit of the Saudi delegation to Uzbekistan. The delegation was headed by Minister of Health Fahd bin Abdulrahman Al-Jaladjel. During this visit, a Uzbek-Saudi business dialogue took place, as well as a round table with the participation of representatives from state bodies, medical institutions, and the private sector.
Reforms and Innovation Cluster
The Director of the Agency for the Development of the Medical and Pharmaceutical Industry, Abdullo Azizov, presented the Saudi side with information about the current reforms in Uzbekistan. These reforms are aimed at modernizing the pharmaceutical industry, developing high value-added production, attracting foreign investment, and increasing the country's export potential.
Participants were also introduced to the pharmaceutical innovation group BioPharma City. This project envisions the creation of infrastructure for scientific research, innovative production, biotechnological development, and international cooperation.
Prospects for Bilateral Partnership
The agreement allows for cooperation not only in the field of pharmaceuticals but also in other areas of medicine. The parties plan to develop investment partnerships, implement joint initiatives, carry out technology transfer, and establish the production of modern medications. Bilateral meetings and negotiations between representatives of Uzbekistan and Saudi Arabia continue within the framework of the official visit of the Saudi delegation.